ALIMERA SCIENCES INC

ANI Pharmaceuticals launched Ketoconazole Shampoo, 2% after FDA approval, aiming to address patient needs with another limited competition product. U.S. annual sales for the shampoo are approximately $69.2 million.

ANI Pharmaceuticals initiated closing logistics for the acquisition of Alimera Sciences, with expected completion pending customary closing conditions.

ANI Pharmaceuticals updates on Alimera Sciences acquisition, noting ongoing good faith discussions to resolve closing conditions.